Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doina Ganea

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|March 4, 2009
Modulation of cannabinoid receptor activation as a neuroprotective strategy for EAE and strokeMing Zhang, Billy R Martin, Martin W Adler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 8, 2017
Prostaglandin E2 Inhibition of IL-27 Production in Murine Dendritic Cells: A Novel Mechanism That Involves IRF1Kirsten M Hooper, Jui-Hung Yen, Weimin Kong, et al.
Journal of Leukocyte Biology|June 11, 2015
Differential effects of IFN-β on IL-12, IL-23, and IL-10 expression in TLR-stimulated dendritic cellsJui-Hung Yen, Weimin Kong, Kirsten M Hooper, et al.
Brain, Behavior, and Immunity|December 11, 2013
Adrenomedullin protects from experimental autoimmune encephalomyelitis at multiple levelsMarta Pedreño, Maria Morell, Gema Robledo, et al.
Immunology and Cell Biology|July 23, 2014
Members of the novel UBASH3/STS/TULA family of cellular regulators suppress T-cell-driven inflammatory responses in vivoTiffanny N Newman, Elisabetta Liverani, Elitza Ivanova, et al.
Clinical Neurosurgery|March 3, 2009
Cannabinoid CB2 receptor activation attenuates motor and autonomic function deficits in a mouse model of spinal cord injuryDarric E Baty, Ming Zhang, Hongbo Li, et al.
Clinical Neurosurgery|March 11, 2010
The combination of selective inhibition of the cannabinoid CB1 receptor and activation of the cannabinoid CB2 receptor yields improved attenuation of motor and autonomic deficits in a mouse model of spinal cord injuryJoshua E Heller, Darric E Baty, Ming Zhang, et al.
Infection and Immunity|October 3, 2012
Microbial amyloids induce interleukin 17A (IL-17A) and IL-22 responses via Toll-like receptor 2 activation in the intestinal mucosaJessalyn H Nishimori, Tiffanny N Newman, Gertrude O Oppong, et al.
Cancers|January 12, 2021
Namodenoson in Advanced Hepatocellular Carcinoma and Child-Pugh B Cirrhosis: Randomized Placebo-Controlled Clinical TrialSalomon M Stemmer, Nebojsa S Manojlovic, Mihai Vasile Marinca, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|March 4, 2009
Modulation of cannabinoid receptor activation as a neuroprotective strategy for EAE and strokeMing Zhang, Billy R Martin, Martin W Adler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 8, 2017
Prostaglandin E2 Inhibition of IL-27 Production in Murine Dendritic Cells: A Novel Mechanism That Involves IRF1Kirsten M Hooper, Jui-Hung Yen, Weimin Kong, et al.
Journal of Leukocyte Biology|June 11, 2015
Differential effects of IFN-β on IL-12, IL-23, and IL-10 expression in TLR-stimulated dendritic cellsJui-Hung Yen, Weimin Kong, Kirsten M Hooper, et al.
Brain, Behavior, and Immunity|December 11, 2013
Adrenomedullin protects from experimental autoimmune encephalomyelitis at multiple levelsMarta Pedreño, Maria Morell, Gema Robledo, et al.
Immunology and Cell Biology|July 23, 2014
Members of the novel UBASH3/STS/TULA family of cellular regulators suppress T-cell-driven inflammatory responses in vivoTiffanny N Newman, Elisabetta Liverani, Elitza Ivanova, et al.
Clinical Neurosurgery|March 3, 2009
Cannabinoid CB2 receptor activation attenuates motor and autonomic function deficits in a mouse model of spinal cord injuryDarric E Baty, Ming Zhang, Hongbo Li, et al.
Clinical Neurosurgery|March 11, 2010
The combination of selective inhibition of the cannabinoid CB1 receptor and activation of the cannabinoid CB2 receptor yields improved attenuation of motor and autonomic deficits in a mouse model of spinal cord injuryJoshua E Heller, Darric E Baty, Ming Zhang, et al.
Infection and Immunity|October 3, 2012
Microbial amyloids induce interleukin 17A (IL-17A) and IL-22 responses via Toll-like receptor 2 activation in the intestinal mucosaJessalyn H Nishimori, Tiffanny N Newman, Gertrude O Oppong, et al.
Cancers|January 12, 2021
Namodenoson in Advanced Hepatocellular Carcinoma and Child-Pugh B Cirrhosis: Randomized Placebo-Controlled Clinical TrialSalomon M Stemmer, Nebojsa S Manojlovic, Mihai Vasile Marinca, et al.
Pageof 8